Search Results 111-120 of 22987 for Phase

1. A Phase I, Multi-Center, Open Label, Dose De-escalation and Expansion Study of Gemcitabine and Cisplatin with AG120 or Pemigatinib for Advanced Cholangiocarcinoma - Mayo Clinic

   Clinical Trials · A Phase I, Multi-Center, Open Label, Dose De-escalation and Expansion Study of Gemcitabine and Cisplatin with AG120 or Pemigatinib for Advanced ...

2. Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies - Mayo Clinic

   Participants from the Phase II OLE study or the Phase III studies who are not eligible or willing to receive etrolizumab in the OLE-SM study, and who have ...

3. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   This clinical trial is a Phase 1-2, open-label, sequential-group, dose-escalation and cohort-expansion study evaluating the safety, pharmacokinetics, ...

4. Chagas disease - Symptoms & causes - Mayo Clinic

   Chronic phase · Irregular heartbeat. · Heart failure. · Sudden cardiac arrest. · Trouble swallowing. · Stomach pain or trouble passing stool, called constipation.

5. Atkins Diet: What's behind the claims? - Mayo Clinic

   What are the phases of the Atkins Diet? · Phase 1: Induction. In this strict phase, you cut out almost all carbohydrates from your diet. · Phase 2: Balancing. In ...

6. Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer - Mayo Clinic

   Clinical Trials · Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer.

7. A Phase 1 Trial of MK-4280 as Monotherapy and in Combination with Pembrolizumab with or without Chemotherapy or Lenvatinib (E7080/MK 7902) in Subjects with Advanced Solid Tumors - Mayo Clinic

   A Phase 1 Trial of MK-4280 as Monotherapy and in Combination with Pembrolizumab with or without Chemotherapy or Lenvatinib (E7080/MK 7902) in Subjects with ...

8. A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

   This is a multicenter, open-label, first-in-human Phase 1 study evaluating the anti programmed death receptor 1 (anti-PD-1) antibody TSR-042 in patients with ...

9. Statin Choice Decision Aid Implementation First Phase - Mayo Clinic

   This proposal represents the first of these phases. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

10. The Mayo Clinic Diet: A weight-loss program for life

    The Mayo Clinic Diet has two phases: Lose It! This two-week phase is designed to jump-start your weight loss, so you may lose up to 6 to 10 pounds ...